Authorisation holders

Takeda Pharma AG: Swissmedic authorisations

Takeda Pharma AG is registered with Swissmedic as the authorisation holder of 50 medicines. The most common category is Synthetic medicines. The list below shows every authorisation with its number and dispensing category.

  • Synthetic medicines24
  • Biotechnological medicines15
  • Blood products10
  • Vaccines1

All medicines from Takeda Pharma AG

Adcetris 50 mgAuthorisation number 62132 · ATC L01FX05AAdvate 250 IE (5 ml)Authorisation number 56352 · ATC B02BD02BAdynovi 250 IE (5 ml)Authorisation number 65953 · ATC B02BD02BAdzynma 500 I.E.Authorisation number 69562 · ATC B01AD13BAgopton 30 mgAuthorisation number 51969 · ATC A02BC03BAlunbrig 30 mgAuthorisation number 66738 · ATC L01ED04ACeprotin 500 I.E.Authorisation number 56124 · ATC B01AD12BCinryze 500 IEAuthorisation number 61636 · ATC B06AC01BCuvitru 200 mg/mlAuthorisation number 65992 · ATC J06BA01BDexilant 30 mgAuthorisation number 62993 · ATC A02BC06BEdarbi 20mgAuthorisation number 62158 · ATC C09CA09BEdarbyclor 40 mg/12.5 mgAuthorisation number 63145 · ATC C09DA09BElapraseAuthorisation number 57916 · ATC A16AB09AElvanse 30 mgAuthorisation number 63023 · ATC N06BA12A+EntyvioAuthorisation number 63285 · ATC L04AG05AEntyvio subkutan 108 mgAuthorisation number 67534 · ATC L04AG05AEntyvio subkutan 108 mgAuthorisation number 67537 · ATC L04AG05AFaktor VII NF TakedaAuthorisation number 41304 · ATC B02BD05BFeiba NF 1000 E. (50 E/ml)Authorisation number 41352 · ATC B02BD03BFirazyr 30 mg/3 mlAuthorisation number 58178 · ATC B06AC02BFosrenol 500 mgAuthorisation number 58073 · ATC V03AE03BFruzaqla 1 mgAuthorisation number 69524 · ATC L01EK04AHyQvia 100 mg/mlAuthorisation number 66684 · ATC J06BA01BImmunate S/D 250 I.E.Authorisation number 52715 · ATC B02BD06BImmunine STIM Plus 600Authorisation number 52474 · ATC B02BD04BIntuniv 1 mgAuthorisation number 66130 · ATC C02AC02BKiovigAuthorisation number 57469 · ATC J06BA02BLivtencity 200 mgAuthorisation number 68492 · ATC J05AX10AMezavantAuthorisation number 65811 · ATC A07EC02BNinlaro 2.3 mgAuthorisation number 65959 · ATC L01XG03APantoprazol Nycomed 20 mgAuthorisation number 59437 · ATC A02BC02BPantoprazol Nycomed i.v.Authorisation number 59436 · ATC A02BC02BPantozol 40 mgAuthorisation number 52710 · ATC A02BC02BPantozol ControlAuthorisation number 59558 · ATC A02BC02DPantozol GranulaAuthorisation number 58661 · ATC A02BC02BPantozol i.v.Authorisation number 55551 · ATC A02BC02BPlenadren 5 mgAuthorisation number 62068 · ATC H02AB09BProthromplex NF 600 I.E.Authorisation number 41330 · ATC B02BD01BQdenga 0.5 mlAuthorisation number 69403 · ATC J07BX04BReplagalAuthorisation number 55774 · ATC A16AB03AResolor 1 mgAuthorisation number 59304 · ATC A06AX05BRevestive 5 mgAuthorisation number 65739 · ATC A16AX08BRiopan 800 mgAuthorisation number 46516 · ATC A02AD02DRiopan Gel 800 mgAuthorisation number 46515 · ATC A02AD02DRixubis 250 IEAuthorisation number 63123 · ATC B02BD04BTAKHZYRO 300 mgAuthorisation number 68178 · ATC B06AC05BTAKHZYRO 300 mgAuthorisation number 70150 · ATC B06AC05BVEYVONDI 650 IEAuthorisation number 66601 · ATC B02BD10BVPRIV 400 UAuthorisation number 61297 · ATC A16AB10BXagrid 0Authorisation number 54720 · ATC L01XX35B

Frequently asked questions

How many medicines does Takeda Pharma AG have authorised in Switzerland?

50 medicines, data as of 01 September 2026. The count covers human medicine authorisations in the Swissmedic export, not individual pack sizes.

What does an authorisation holder do?

The authorisation holder applies for the authorisation, maintains it, owns the product information, reports adverse reactions to Swissmedic and keeps the product available. Under Art. 10 TPA it must have a registered office in Switzerland.

Can an authorisation be transferred?

Yes. The transfer of an authorisation to a new holder is notified to Swissmedic and carries a fee. Product information, packaging material and pharmacovigilance responsibility transfer with it.

Dispute this entry

We are happy to correct entries. Send us a note through the form, we check it against the current Swissmedic export and update the record.

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com

Sources

Swissmedic data as of 01 September 2026

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com